Early treatments for COVID-19
The 2,260 treatments below have been reported as potentially beneficial for early treatment of COVID-19. We currently review studies for:
acetaminophen
antiandrogens
aspirin
bamlanivimab/etesevimab
bebtelovimab
bromhexine
budesonide
cannabidiol
casirivimab/imdevimab
colchicine
convalescent plasma
curcumin
diet
ensitrelvir
ensovibep
exercise
famotidine
favipiravir
fluvoxamine
HCQ
ibuprofen
indomethacin
iota-carrageenan
ivermectin
lactoferrin
melatonin
metformin
molnupiravir
N-acetylcysteine
nigella sativa
nitazoxanide
nitric oxide
paxlovid
peginterferon lambda
povidone-iodine
probiotics
proxalutamide
quercetin
remdesivir
sleep
sotrovimab
spironolactone
sunlight
tixagevimab/cilgavimab
vitamin A
vitamin C
vitamin D
zinc
The following papers report potential benefits of 2,212
other treatments. We have not reviewed these studies.
Sort by number of studies
Sort alphabetically
Submit updates
glycyrrhiza glabra
resveratrol
rutin
camostat
Luteolin
kaempferol
Artemisia annua
Hesperidin
lopinavir
amantadine
arbidol
ritonavir
baricitinib
catechin
epigallocatechin
myricetin
Apigenin
nafamostat
ribavirin
azithromycin
Baicalin
darunavir
dexamethasone
fluoxetine
niclosamide
Andrographolide
atorvastatin
boceprevir
ellagic acid
emodin
galidesivir
ozone therapy
apilimod
Baicalein
cepharanthine
chloroquine
estradiol
glycyrrhizin
sofosbuvir
amentoflavone
atazanavir
azvudine
carvedilol
daclatasvir
doxycycline
emetine
gallic acid
glutathione
hypericin
loratadine
losartan
masitinib
methotrexate
Omega 3
saquinavir
sirolimus
theaflavin
thiamine
xylitol
amiodarone
APN01
Azelastine
berberine
cetirizine
cetylpyridinium chloride
chlorogenic acid
clofazimine
fenofibrate
fostamatinib
fucoidan
genistein
hydrogen peroxide
isorhamnetin
methylene blue
monolaurin
mycophenolic acid
myricitrin
oleuropein
pectolinarin
(more...)